MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conferences: 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022, at 3:00 pm Eastern Time (12:00 pm Pacific Time) Cowen 42nd Annual Health Care Conference on March 7, 2022, at... Read more
ANDOVER, Mass. , Feb. 08, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more
On February 4, we celebrate World Cancer Day – a day that unites people, communities and entire countries to raise awareness and take action. Cancer is a global challenge. 10 million people die from cancer every year. This year’s World Cancer Day‘s theme, “Close the Care Gap”, raises awareness of the equity gap that affects almost everyone,... Read more
Basel, 03 February 2022 Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francs Pharmaceuticals Division sales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilars Diagnostics Division sales grow 29%; strong momentum in base business and continued high demand for COVID-19 tests Major... Read more
Basel, 1 February 2022 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that William Pao (1967), M.D., Ph.D., and Head of Roche Pharma Research and Early Development (pRED) since 2018, has decided to leave Roche for a new opportunity and return to the United States, effective 18 March 2022. Johannes (Hans) Clevers (1957), M.D., Ph.D.,... Read more
FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection and immune monitoring... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 27, 2022– Xylem (NYSE:XYL), a leading global water technology company, has today announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index. This is the third year in a row that Xylem has earned top marks on the U.S. benchmarking survey which measures... Read more